⚖️Limited Exclusion Orders and Cease and Desist Rulings on Hydrodermabrasion Systems
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order ("LEO") barring entry of certain hydrodermabrasion systems and components thereof by or on behalf of respondents Medical Purchasing Resource, LLC, Bio-Infusions USA Inc., MIRAmedtech UG, eMIRAmed USA, LLC, and MIRAmedtech SP. Z.O.O. (collectively, "Defaulting Respondents"); and cease and desist orders ("CDOs") against the Defaulting Respondents. The investigation is terminated.
Learn More📡Investigation Notice on Integrated Circuits and Patent Infringement
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 18, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Onesta IP, LLC of Wayne, Pennsylvania. A letter supplementing the complaint was filed on May 8, 2025. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain integrated circuits, electronic devices containing the same, and components thereof by reason of the infringement of certain claims of U.S. Patent No. 8,854,381 ("the '381 patent"); U.S. Patent No. 9,519,943 ("the '943 patent"); U.S. Patent No. 7,717,350 ("the '350 patent"); U.S. Patent No.11,741,019 ("the '019 patent"); U.S. Patent No. 11,841,803 ("the '803 patent"); and U.S. Patent No. 9,116,809 ("the `809 patent"). The complaint further alleges that an industry in the United States exists or is in the process of being established as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More⚖️Investigation into Balloon Dilation Device Patent Infringement Announced
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 18, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Entellus Medical, Inc. of Plymouth, Minnesota, Stryker Corporation of Portage, Michigan, and Stryker Sales, LLC of Portage, Michigan. Supplements to the complaint were filed on April 25 and May 8, 2025. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain balloon dilation devices, systems, and components thereof by reason of the infringement of certain claims of U.S. Patent No. 11,083,878 ("the '878 patent"); U.S. Patent No. 11,090,472 ("the '472 patent"); and U.S. Patent No. 12,274,847 ("the '847 patent"). The complaint further alleges that an industry in the United States exists or is in the process of being established as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More📺Investigation Notice
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 11, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Nokia Technologies Oy of Finland and Nokia Corporation of Finland. Supplements to the complaint were filed on April 21, April 24 and May 2, 2025. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain video-capable laptop, desktop computers, handheld computers, tablets, televisions, projectors, and components and modules thereof by reason of the infringement of certain claims of U.S. Patent No. 9,036,701 ("the '701 patent"); U.S. Patent No. 10,536,714 ("the '714 patent"); U.S. Patent No. 11,805,267 ("the '267 patent"); and U.S. Patent No. 8,050,321 ("the '321 patent"). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More💊ITC Investigation on Drug Products and Patent Violations
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on April 2, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of BioMarin Pharmaceutical Inc. of Novato, California. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain drug products containing C-type natriuretic peptide variants and components thereof by reason of the infringement of certain claims of U.S. Reissue Patent No. RE48,267 (the "RE'267 patent"). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More💼ITC Notice
Notice is hereby given that the U.S. International Trade Commission has determined to (1) not review an initial determination ("ID") (Order No. 44) issued by the presiding administrative law judge ("ALJ") granting a motion filed by JBS Hair, Inc. ("JBS Hair") to terminate the investigation as to the remaining active respondents based on withdrawal of the complaint, and (2) to request written submissions from the parties, interested government agencies, and interested persons, under the schedule set forth below, on remedy, the public interest, and bonding with respect to respondents previously found to be in default.
Learn More📜ITC Notice
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 10) of the presiding administrative law judge ("ALJ") granting Complainant's unopposed motion to terminate the investigation as to one respondent based on settlement, and an ID (Order No. 11) amending the Notice of Investigation and granting Complainant's unopposed motion to terminate the above- captioned investigation as to another respondent based on settlement.
Learn More⚖️USITC Regulation on Hydrodermabrasion Systems and Settlement Outcomes
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 16) issued by the presiding administrative law judge ("ALJ") terminating the investigation as to the remaining active respondents based on settlement, and to request written submissions from the parties, interested government agencies, and interested persons, under the schedule set forth below, on remedy, the public interest, and bonding.
Learn More🔧Limited Exclusion Order on Injection Molding Components
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order ("LEO") barring entry of certain components for injection molding machines, and products containing the same by or on behalf of respondent Ningbo AO Sheng Mold Co., Ltd., d/b/a AOSIMI ("AOSIMI") previously found to be in default. The investigation is terminated.
Learn More⚡Investigation Notice on Active Electrical Cables Patent Infringement
Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on March 13, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of Credo Semiconductor Inc. of San Jose, California and Credo Technology Group Ltd. of the Cayman Islands. An amended complaint was filed on March 18, 2025. A supplement to the amended complaint was filed on March 27, 2025. A second supplement was filed on March 31, 2025. A third supplement was filed on April 7, 2025. The amended complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain active electrical cables and components thereof by reason of the infringement of certain claims of U.S. Patent No. 10,877,233 ("the '233 patent"); U.S. Patent No. 11,012,252 ("the '252 patent"); and U.S. Patent No. 11,032,111 ("the '111 patent"). The amended complaint, as supplemented, further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainants request that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.
Learn More